Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines.
Matsuda T, Almasan A, Tomita M, Uchihara JN, Masuda M, Ohshiro K, Takasu N, Yagita H, Ohta T, Mori N. Matsuda T, et al. Among authors: uchihara jn. J Virol. 2005 Feb;79(3):1367-78. doi: 10.1128/JVI.79.3.1367-1378.2005. J Virol. 2005. Retraction in: J Virol. 2011 Feb;85(3):1416. doi: 10.1128/JVI.02070-10 PMID: 15650163 Free PMC article. Retracted.
Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells.
Tomita M, Kawakami H, Uchihara JN, Okudaira T, Masuda M, Takasu N, Matsuda T, Ohta T, Tanaka Y, Ohshiro K, Mori N. Tomita M, et al. Among authors: uchihara jn. Int J Cancer. 2006 Feb 1;118(3):765-72. doi: 10.1002/ijc.21389. Int J Cancer. 2006. Retraction in: Int J Cancer. 2011 Dec 1;129(11):2762-3. doi: 10.1002/ijc.26387 PMID: 16106398 Retracted.
Transactivation of CCL20 gene by Epstein-Barr virus latent membrane protein 1.
Okudaira T, Yamamoto K, Kawakami H, Uchihara JN, Tomita M, Masuda M, Matsuda T, Sairenji T, Iha H, Jeang KT, Matsuyama T, Takasu N, Mori N. Okudaira T, et al. Among authors: uchihara jn. Br J Haematol. 2006 Feb;132(3):293-302. doi: 10.1111/j.1365-2141.2005.05877.x. Br J Haematol. 2006. Retraction in: Br J Haematol. 2011 Mar;152(6):787. doi: 10.1111/j.1365-2141.2011.08571.x PMID: 16409294 Free article. Retracted.
NIK-333 inhibits growth of human T-cell leukemia virus type I-infected T-cell lines and adult T-cell leukemia cells in association with blockade of nuclear factor-kappaB signal pathway.
Okudaira T, Tomita M, Uchihara JN, Matsuda T, Ishikawa C, Kawakami H, Masuda M, Tanaka Y, Ohshiro K, Takasu N, Mori N. Okudaira T, et al. Among authors: uchihara jn. Mol Cancer Ther. 2006 Mar;5(3):704-12. doi: 10.1158/1535-7163.MCT-05-0434. Mol Cancer Ther. 2006. PMID: 16546985
Overexpression of Aurora A by loss of CHFR gene expression increases the growth and survival of HTLV-1-infected T cells through enhanced NF-kappaB activity.
Tomita M, Toyota M, Ishikawa C, Nakazato T, Okudaira T, Matsuda T, Uchihara JN, Taira N, Ohshiro K, Senba M, Tanaka Y, Ohshima K, Saya H, Tokino T, Mori N. Tomita M, et al. Among authors: uchihara jn. Int J Cancer. 2009 Jun 1;124(11):2607-15. doi: 10.1002/ijc.24257. Int J Cancer. 2009. Retraction in: Int J Cancer. 2011 Dec 1;129(11):2762-3. doi: 10.1002/ijc.26387 PMID: 19230025 Retracted.
33 results